Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

NCT00769704 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

437

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: Talimogene laherparepvec
BIOLOGICAL: GM-CSF

Sponsor

BioVex Limited

Collaborators

[object Object]